ATE369144T1 - Verfahren zur steigerung des haarwuchses durch wnt polypeptid - Google Patents

Verfahren zur steigerung des haarwuchses durch wnt polypeptid

Info

Publication number
ATE369144T1
ATE369144T1 AT01926479T AT01926479T ATE369144T1 AT E369144 T1 ATE369144 T1 AT E369144T1 AT 01926479 T AT01926479 T AT 01926479T AT 01926479 T AT01926479 T AT 01926479T AT E369144 T1 ATE369144 T1 AT E369144T1
Authority
AT
Austria
Prior art keywords
hair growth
wnt polypeptide
wnt
increase hair
methods
Prior art date
Application number
AT01926479T
Other languages
English (en)
Inventor
Jiro Kishimoto
Robert Burgeson
Bruce Morgan
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE369144T1 publication Critical patent/ATE369144T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0627—Hair cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01926479T 2000-03-31 2001-03-30 Verfahren zur steigerung des haarwuchses durch wnt polypeptid ATE369144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19377100P 2000-03-31 2000-03-31
US26169001P 2001-01-12 2001-01-12

Publications (1)

Publication Number Publication Date
ATE369144T1 true ATE369144T1 (de) 2007-08-15

Family

ID=26889330

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926479T ATE369144T1 (de) 2000-03-31 2001-03-30 Verfahren zur steigerung des haarwuchses durch wnt polypeptid

Country Status (9)

Country Link
US (4) US6924141B2 (de)
EP (1) EP1267616B1 (de)
JP (3) JP4813734B2 (de)
AT (1) ATE369144T1 (de)
AU (2) AU5301201A (de)
CA (1) CA2403817C (de)
DE (1) DE60129799T2 (de)
ES (1) ES2290125T3 (de)
WO (1) WO2001074164A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267616B1 (de) * 2000-03-31 2007-08-08 The General Hospital Corporation Verfahren zur steigerung des haarwuchses durch wnt polypeptid
AU2002238568A1 (en) * 2001-03-07 2002-09-19 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Identification and use of inhibitors of hair growth
US20050130181A1 (en) * 2001-05-18 2005-06-16 Sirna Therapeutics, Inc. RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)
WO2003086334A1 (fr) * 2002-04-17 2003-10-23 Taisho Pharmaceutical Co., Ltd. Produit tonique pour la pousse de cheveux
EP1546392A4 (de) * 2002-08-02 2006-05-24 Stratatech Corp Spezies-spezifischer dna-nachweis
US7785876B2 (en) 2002-11-14 2010-08-31 Aderans Research Institute, Inc. Cultivation of hair inductive cells
US20060172304A1 (en) * 2003-02-27 2006-08-03 Elaine Fuchs Method for modulating epithelial stem cell lineage
PT2157192E (pt) 2003-10-10 2013-11-28 Deutsches Krebsforsch Composições para diagnóstico e terapia de doenças associadas com a expressão aberrante de futrinas (r-espondinas)
WO2005084223A2 (en) * 2004-02-27 2005-09-15 The General Hospital Corporation Methods and compositions for hair growth
WO2006026617A2 (en) * 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions and methods of promoting hair growth
JP2008511672A (ja) * 2004-08-30 2008-04-17 セレゲン，インコーポレーテッド 培養三次元組織およびその使用
WO2006036175A2 (en) * 2004-09-21 2006-04-06 Rhode Island Hospital, A Lifespan-Partner Wnt proteins and detection and treatment of cancer
CA2580780A1 (en) * 2004-09-21 2006-04-06 Rhode Island Hospital, A Lifespan-Partner Frizzled proteins and detection and treatment of cancer
US7850960B2 (en) * 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
JP2008179540A (ja) * 2005-01-07 2008-08-07 Noevir Co Ltd 細胞分化、発生、増殖を制御する物質および該物質を含む細胞分化・発生・増殖調節剤
CN101128212A (zh) * 2005-01-18 2008-02-20 国立大学法人京都大学 用于神经细胞再生的药物
AU2012204059B2 (en) * 2005-03-29 2015-01-15 The Trustees Of The University Of Pennsylvania Methods for generating new hair follicles, treating baldness and hair removal
EP2949328B1 (de) 2005-03-29 2022-07-20 The Trustees of The University of Pennsylvania Minoxidil zur erzeugung neuer haarfollikel und behandlung
JP5702519B2 (ja) * 2005-04-07 2015-04-15 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ａａｖベクターの機能を上げる方法
US8227244B2 (en) * 2005-05-16 2012-07-24 The Rockefeller University Method for isolating dermal papilla cells and uses thereof
US20070148138A1 (en) 2005-11-22 2007-06-28 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
WO2007100870A2 (en) 2006-02-28 2007-09-07 The Trustees Of Columbia University In The City Of New York Methods for compact aggregation of dermal cells
GB0605450D0 (en) 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
ES2419232T3 (es) * 2006-06-27 2013-08-20 Shiseido Company, Limited Agregado de células que comprende diversas clases de células derivadas del soma con capacidad para formar una estructura de tipo órgano primitivo
CA2664697A1 (en) 2006-09-28 2008-04-10 Follica, Inc. Methods, kits, and compositions for generating new hair follicles and growing hair
US7922688B2 (en) 2007-01-08 2011-04-12 Restoration Robotics, Inc. Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions
US8580236B2 (en) * 2007-03-19 2013-11-12 Richard P. De Maria Hair sustaining formulation
DK2173379T3 (en) 2007-07-02 2015-12-07 Oncomed Pharm Inc Compositions and methods for treatment and diagnosis of cancer
JP5300273B2 (ja) * 2008-01-21 2013-09-25 株式会社 資生堂 ヒトＷｎｔ３ａ遺伝子形質転換細胞
KR101650957B1 (ko) * 2008-01-30 2016-08-24 히스토젠, 인코포레이티드 세포외 기질 조성물
US8535913B2 (en) * 2008-01-30 2013-09-17 Histogen, Inc. Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells
US20100166824A1 (en) * 2008-01-30 2010-07-01 Histogen, Inc. Extracellular matrix compositions
US8530415B2 (en) * 2008-01-30 2013-09-10 Histogen, Inc. Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions
US8524494B2 (en) * 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
FR2936255B1 (fr) * 2008-09-19 2010-10-15 Galderma Res & Dev Modulateurs de fzd2 dans le traitement de l'alopecie
JP5723780B2 (ja) * 2008-11-12 2015-05-27 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 創傷形成後の毛包再生を促進する繊維芽細胞増殖因子‐９
US20120046242A1 (en) * 2008-12-24 2012-02-23 Massachusetts Institute Of Technology Molecular activators of the wnt/beta-catenin pathway
KR101198918B1 (ko) * 2009-09-01 2012-11-07 (주)케어젠 Ｗｎｔ１０?유래 펩타이드 및 그의 용도
WO2011049958A2 (en) * 2009-10-21 2011-04-28 Otonomy, Inc. Modulation of gel temperature of poloxamer-containing formulations
KR101209117B1 (ko) 2010-03-25 2012-12-06 (주)케어젠 변형된 ｗｎｔ１０?유래 펩타이드 및 그의 용도
JP6071875B2 (ja) * 2010-06-18 2017-02-08 ザ ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン，インコーポレイティド 毛包新生
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012174280A2 (en) 2011-06-15 2012-12-20 The Regents Of The University Of California Methods and compositions for modulating myofibroblast activities
EP2731625B1 (de) 2011-07-15 2018-04-18 OncoMed Pharmaceuticals, Inc. Rspo-bindende stoffe und ihre verwendung
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
CA2878868A1 (en) 2012-07-13 2014-01-16 Austin L. Gurney Rspo3 binding agents and uses thereof
CN104031055B (zh) * 2013-03-07 2016-08-24 中国科学院上海生命科学研究院 一种可用作Wnt信号途径激活剂的化合物及其制备与应用
WO2014179559A1 (en) 2013-05-03 2014-11-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
JP6796059B2 (ja) 2014-09-12 2020-12-02 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Ｗｎｔシグナリングアゴニスト分子
WO2016044295A1 (en) 2014-09-16 2016-03-24 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
US20180161389A1 (en) * 2015-01-09 2018-06-14 The Board Of Trustees Of The Leland Stanford Junior University R-spondin agonist-mediated hair growth
WO2018125746A1 (en) 2016-12-30 2018-07-05 Frequency Therapeutics, Inc. 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells
CN106727682A (zh) * 2017-01-20 2017-05-31 李玉红 一种用于治疗脱发的制剂
EP3609998A1 (de) * 2017-04-11 2020-02-19 Frequency Therapeutics, Inc. Verfahren zur haarfollikelstammzellenproliferation
WO2018232154A1 (en) 2017-06-15 2018-12-20 Belite Bio, Inc Methods of treating metabolic diseases with fused bicyclic pyrazoles
NZ764440A (en) * 2017-11-16 2024-03-22 Aivita Biomedical Inc Use of cell membrane-bound signaling factors
CN111655729B (zh) 2017-12-19 2023-10-20 瑟罗泽恩奥普瑞汀公司 抗卷曲蛋白抗体和使用方法
CN111699003B (zh) 2017-12-19 2024-05-03 瑟罗泽恩奥普瑞汀公司 抗lrp5/6抗体和使用方法
US11773171B2 (en) 2017-12-19 2023-10-03 Surrozen Operating, Inc. WNT surrogate molecules and uses thereof
TWI665217B (zh) * 2018-03-07 2019-07-11 臺鹽實業股份有限公司 膠原蛋白衍生胜肽及其用於製備促進生髮組成物之用途
GB201816902D0 (en) * 2018-10-17 2018-11-28 Hairclone Ltd Hair Rejuvenation
KR102242840B1 (ko) * 2019-04-04 2021-04-23 주식회사 비알팜 탈모 방지 또는 발모 촉진용 조성물
WO2021007172A1 (en) 2019-07-08 2021-01-14 Belite Bio, Llc Formulations of rbp4 inhibitors and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091173A (en) * 1989-06-29 1992-02-25 The University Of Dundee Hair growth composition
US5208145A (en) * 1991-05-06 1993-05-04 The Salk Institute For Biological Studies Assay for the presence, in cultured cells, of functional ligand-gated channels, and substances which enhance intracellular lithium accumulation by cultured cells via such channels
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
CA2177061A1 (en) 1993-12-22 1995-06-29 Gideon A. Rodan Dna encoding the wnt-x growth factor
JP3573488B2 (ja) * 1994-04-11 2004-10-06 独立行政法人 科学技術振興機構 毛乳頭細胞の長期継代培養法
JP2991620B2 (ja) * 1994-08-30 1999-12-20 科学技術振興事業団 細胞活動の制御方法
AU7672996A (en) 1995-11-13 1997-06-05 Regents Of The University Of California, The Methods and compositions for hair growth promotion
WO1999042481A2 (de) * 1998-02-21 1999-08-26 Max-Delbrück-Centrum für Molekulare Medizin MITTEL ZUR THERAPIE VON MENSCHLICHEN ERKRANKUNGEN, AUSGEHEND VON β-CATENIN, SEINE HERSTELLUNG UND SEINE VERWENDUNG
US6485972B1 (en) * 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
US6159950A (en) * 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
WO2000031134A1 (en) * 1998-11-20 2000-06-02 Arch Development Corporation Regulation of hair follicle morphogenesis based on beta-catenin
EP1267616B1 (de) * 2000-03-31 2007-08-08 The General Hospital Corporation Verfahren zur steigerung des haarwuchses durch wnt polypeptid

Also Published As

Publication number Publication date
WO2001074164A1 (en) 2001-10-11
US6924141B2 (en) 2005-08-02
US20040170611A1 (en) 2004-09-02
US7985587B2 (en) 2011-07-26
EP1267616A1 (de) 2003-01-02
JP2014159471A (ja) 2014-09-04
DE60129799D1 (de) 2007-09-20
EP1267616A4 (de) 2003-07-16
EP1267616B1 (de) 2007-08-08
CA2403817C (en) 2012-05-29
AU5301201A (en) 2001-10-15
DE60129799T2 (de) 2008-04-30
AU2001253012B2 (en) 2006-02-23
US20080286261A1 (en) 2008-11-20
US20020114772A1 (en) 2002-08-22
US7175842B2 (en) 2007-02-13
JP4813734B2 (ja) 2011-11-09
JP5580252B2 (ja) 2014-08-27
US20050271632A1 (en) 2005-12-08
CA2403817A1 (en) 2001-10-11
JP2004500407A (ja) 2004-01-08
JP2011207908A (ja) 2011-10-20
ES2290125T3 (es) 2008-02-16
WO2001074164A9 (en) 2002-01-10
JP5960749B2 (ja) 2016-08-02

Similar Documents

Publication Publication Date Title
ATE369144T1 (de) Verfahren zur steigerung des haarwuchses durch wnt polypeptid
ATE375999T1 (de) Zusammensetzungen und verfahren zur behandlung von diabetes
WO2003089457A3 (en) Peptide inhibitors of protein kinase c ϝ for pain management
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
DE59912716D1 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
ATE471722T1 (de) Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen
NO20055309L (no) Slurp-1 samrnensetninger og fremgangsmater for anvendelse derav
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
MX2007005054A (es) Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.
DE602004018249D1 (de) Verfahren zur Dearomatisierung von Molkeprotein
DE60037886D1 (de) Verfahren zur reinigung von rekombinanten proteinen, welche wachstumshormon antagonisten sind, mittels wässriger zweiphasen-extraktion
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
ATE406438T1 (de) Menschliches homolog aus der familie der metalloproteasen
DE50304687D1 (de) Verfahren zur herstellung von benzophenonen
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
ATE517629T1 (de) Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
DE602004023811D1 (de) Verfahren zur modularen Potenzierung zur Entschlüsselung bzw. zur Erzeugung von digitalen Signaturen
DE602004003966D1 (de) Verbessertes verfahren zur herstellung von alpha-polymorphem eletriptan hydrobromid
MXPA06013176A (es) Dominios semejantes al factor de crecimiento epidermico de mucina 3.
ATE402948T1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
ATE512983T1 (de) Rezeptor für das tgr3-like protein
DE60325737D1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
DE60119458D1 (de) Vorrichtung zur Feststellung der genetischen Sequenz von Biopolymeren
DE50205026D1 (de) Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties